Highnoon Laboratories Limited: Potential Acquisition Announced
Summary
Highnoon Laboratories considers potential acquisition to expand strategic position, pending regulatory approvals.
Kind of disclosure: Other
Read the original filingKey facts
- Potential acquisition announced
- Evaluation stage
- Board meeting held
- 2026-02-02
- Regulatory approvals pending
- Necessary for acquisition
Highnoon Laboratories Limited (HINOON) on Nafa
Last price Rs 960.87 · Pharmaceuticals · You can own HINOON shares from your phone.
More HINOON announcements
- NoticeTransmission of Quarterly Report for the Period Ended September 30, 2026
- Financial resultFinancial Results for the Quarter EndedHighnoon Laboratories Limited reported a revenue of Rs 21.49 billion and a net profit of Rs 2.71 billion for the nine months ended September 30, 2026, showing moderate growth compared to the previous year.
- NoticeBoard Meeting
- Insider tradeDirector Tehmina Saeed Chaudhury sold 10,000 shares at Rs 916.71Filed as: Insider Transaction
- NoticeTransmission of Quarterly Report for the Period Ended 30.06.2026
- NoticeBoard Meeting
Source: Highnoon Laboratories Limited's filing with the Pakistan Stock Exchange. The summary and figures on this page are extracted from the filing by software and can contain errors; the filing itself is the record. This page describes the filing. It is not investment advice and Nafa does not recommend any stock. Investing in securities involves risk, including possible loss of principal.